NCT04423016

Brief Summary

The transitional period, defined as the first 72 hours after preterm birth, is often characterized by a significant hemodynamic instability and may also be associated with an impairment of cerebral autoregulation, with relevant clinical implications. The moving correlation coefficient between cerebral oxygenation and heart rate, also defined as TOHRx, has been previously proposed as a marker of cerebrovascular reactivity and provides an indirect estimation of cerebral autoregulation in preterm infants. This study aims to evaluate whether different antenatal, perinatal and postnatal factors may influence cerebrovascular reactivity in very preterm infants during the transitional period.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2018

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 21, 2018

Completed
2.3 years until next milestone

First Submitted

Initial submission to the registry

June 5, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 9, 2020

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2021

Completed
3 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 3, 2021

Completed
Last Updated

July 28, 2021

Status Verified

July 1, 2021

Enrollment Period

3.4 years

First QC Date

June 5, 2020

Last Update Submit

July 26, 2021

Conditions

Keywords

cerebral autoregulationcerebrovascular reactivitypreterm infantstransitional period

Outcome Measures

Primary Outcomes (6)

  • Correlation between TOHRx and gestational age

    Correlation between TOHRx and gestational age

    0-72 hours

  • Correlation between TOHRx and antenatal steroids administration

    Correlation between TOHRx and antenatal steroids administration (full course vs. incomplete course or not given)

    0-72 hours

  • Correlation between TOHRx and antenatal Doppler status

    Correlation between TOHRx and antenatal Doppler status (normal or abnormal)

    0-72 hours

  • Correlation between TOHRx and ductal status

    Correlation between TOHRx and ductal status (hemodynamically significant, restrictive or closed)

    0-72 hours

  • Correlation between TOHRx and respiratory support

    Correlation between TOHRx and respiratory support modality (mechanical ventilation, CPAP, nasal cannulas or self-ventilating in air)

    0-72 hours

  • Correlation between TOHRx and inotropes

    Correlation between TOHRx and inotropes administration (dopamine; dobutamine; dopamine and dobutamine)

    0-72 hours

Interventions

Non-invasive continuous monitoring of cerebral oxygenation

Non-invasive continuous monitoring of cerebral oxygenation

Eligibility Criteria

Age1 Day - 3 Days
Sexall
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Preterm infants \<32 weeks' gestation during the transitional period (0-72 hours of life)

You may qualify if:

  • gestational age \<32 weeks' gestation

You may not qualify if:

  • major congenital malformations
  • congenital heart disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sant'Orsola-Malpighi University Hospital

Bologna, Emilia-Romagna, 40138, Italy

Location

MeSH Terms

Conditions

Premature Birth

Interventions

Oximetry

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Intervention Hierarchy (Ancestors)

Blood Gas AnalysisBlood Chemical AnalysisClinical Chemistry TestsClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisHeart Function TestsDiagnostic Techniques, CardiovascularRespiratory Function TestsDiagnostic Techniques, Respiratory SystemInvestigative Techniques

Study Officials

  • Luigi Corvaglia, MD

    S. Orsola-Malpighi University Hospital, Bologna, Italy

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

June 5, 2020

First Posted

June 9, 2020

Study Start

February 21, 2018

Primary Completion

June 30, 2021

Study Completion

July 3, 2021

Last Updated

July 28, 2021

Record last verified: 2021-07

Data Sharing

IPD Sharing
Will not share

Locations